FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Lesinurad/Allopurinol (DUZALLO®) Tablets
Status: Discontinuation
»Therapeutic Categories:

Expand all

Ironwood Pharmaceuticals Inc. (New 04/15/2019)

Company Contact Information:
844-374-4793

Presentation Posting Date Related Information
200/200mg tablets 5 count bottle (NDC 70785-021-05) 04/15/2019 Ironwood Pharmaceuticals, Inc. has made a business-related decision to discontinue Duzallo.
200/200 mg tablets 30 count bottle (NDC 70785-021-30) 04/15/2019 Ironwood Pharmaceuticals, Inc. has made a business-related decision to discontinue Duzallo.
200/200 mg tablets 90 count bottle (NDC 70785-021-90) 04/15/2019 Ironwood Pharmaceuticals, Inc. has made a business-related decision to discontinue Duzallo.
200/300 mg tablets 5 count bottle (NDC 70785-022-05) 04/15/2019 Ironwood Pharmaceuticals, Inc. has made a business-related decision to discontinue Duzallo.
200/300 mg tablets 30 count bottle (NDC 70785-022-30) 04/15/2019 Ironwood Pharmaceuticals, Inc. has made a business-related decision to discontinue Duzallo.
200/300 mg tablets 90 count bottle (NDC 70785-022-90) 04/15/2019 Ironwood Pharmaceuticals, Inc. has made a business-related decision to discontinue Duzallo.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English